The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients
Abstract Aim The Xiaoke Pill containing Chinese herb extracts and Glibenclamide, is used in therapy for type 2 diabetes mellitus (T2DM), and is effective in reducing the risk of hypoglycemia and improving diabetes symptoms compared with Glibenclamide. We describe a quantitative proteomics project to...
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
BMC
2017-05-01
|
| Saila: | Clinical Proteomics |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s12014-017-9154-0 |